INT143162

From wiki-pain
Revision as of 02:45, 21 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.78
First Reported 2006
Last Reported 2007
Negated 0
Speculated 1
Reported most in Abstract
Documents 7
Total Number 14
Disease Relevance 5.86
Pain Relevance 0.49

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (S100a6) nuclear envelope (S100a6) plasma membrane (S100a6)
nucleus (S100a6) cytoplasm (S100a6)
Anatomy Link Frequency
uterus 2
adipocyte 2
epithelial cells 1
S100a6 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Chronic pancreatitis 12 99.60 Very High Very High Very High
Potency 24 5.00 Very Low Very Low Very Low
agonist 16 5.00 Very Low Very Low Very Low
Dismenorea 8 5.00 Very Low Very Low Very Low
antagonist 8 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 50 99.84 Very High Very High Very High
Pancreatic Cancer 24 99.82 Very High Very High Very High
Pancreatitis 30 99.60 Very High Very High Very High
Ductal Carcinoma 12 99.48 Very High Very High Very High
Malignant Neoplastic Disease 6 95.76 Very High Very High Very High
Breast Cancer 8 42.28 Quite Low
Obesity 16 11.56 Low Low
Hypersensitivity 32 5.00 Very Low Very Low Very Low
Dysmenorrhea 8 5.00 Very Low Very Low Very Low
Reprotox - General 1 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In the present study, we measured S100A6 expression in pancreatic tissues and juice to evaluate its involvement in pancreatic carcinogenesis.
Gene_expression (expression) of S100A6
1) Confidence 0.78 Published 2007 Journal Cancer Epidemiol. Biomarkers Prev. Section Abstract Doc Link 17416753 Disease Relevance 0.57 Pain Relevance 0
In analyses of pancreatic juice, IPMN and pancreatic cancer samples expressed significantly higher levels of S100A6 than did chronic pancreatitis samples (both; P < 0.017), but levels in pancreatic cancer and IPMN samples did not differ form each other.
Gene_expression (expressed) of S100A6 associated with cancer, pancreatic cancer and chronic pancreatitis
2) Confidence 0.78 Published 2007 Journal Cancer Epidemiol. Biomarkers Prev. Section Abstract Doc Link 17416753 Disease Relevance 1.44 Pain Relevance 0.17
The present data suggest that expression of S100A6 is increased in a stepwise manner during pancreatic carcinogenesis and may be a biomarker for evaluating malignant potential.
Gene_expression (expression) of S100A6 associated with malignant neoplastic disease
3) Confidence 0.78 Published 2007 Journal Cancer Epidemiol. Biomarkers Prev. Section Abstract Doc Link 17416753 Disease Relevance 1.28 Pain Relevance 0.18
There are few reports describing the diagnostic significance of S100A6 expression in clinical samples obtained from patients with pancreatic disease.
Gene_expression (expression) of S100A6 associated with pancreatitis
4) Confidence 0.78 Published 2007 Journal Cancer Epidemiol. Biomarkers Prev. Section Abstract Doc Link 17416753 Disease Relevance 0.36 Pain Relevance 0
Microdissected invasive ductal carcinoma and intraductal papillary mucinous neoplasm (IPMN) cells expressed significantly higher levels of S100A6 than did microdissected pancreatitis-affected epithelial and normal cells (all comparison; P < 0.008).
Gene_expression (expressed) of S100A6 associated with ductal carcinoma, cancer and pancreatitis
5) Confidence 0.78 Published 2007 Journal Cancer Epidemiol. Biomarkers Prev. Section Abstract Doc Link 17416753 Disease Relevance 1.05 Pain Relevance 0.06
In addition, treatment with estrogenic compounds resulted in a significant increase in the expression of calcyclin mRNA, whose level paralleled those of oxytocin and Acrp30, as shown in the Additional file 1 and Fig. 3.
Gene_expression (expression) of calcyclin mRNA
6) Confidence 0.65 Published 2006 Journal Reprod Biol Endocrinol Section Body Doc Link PMC1594574 Disease Relevance 0 Pain Relevance 0
As shown in Fig. 3, the expression level of calcium binding protein A6 (S100a6) in this tissue significantly increased when treated with OP (3.1-fold) and NP (4.2-fold).
Gene_expression (expression) of S100a6
7) Confidence 0.65 Published 2006 Journal Reprod Biol Endocrinol Section Body Doc Link PMC1594574 Disease Relevance 0 Pain Relevance 0
The effect of E2 on the expression level of calcyclin mRNA in uteri was further examined to elucidate a relationship between expression levels of calcyclin and estrogenic compounds.
Gene_expression (expression) of calcyclin
8) Confidence 0.65 Published 2006 Journal Reprod Biol Endocrinol Section Body Doc Link PMC1594574 Disease Relevance 0 Pain Relevance 0
The effect of E2 on the expression level of calcyclin mRNA in uteri was further examined to elucidate a relationship between expression levels of calcyclin and estrogenic compounds.
Gene_expression (expression) of calcyclin mRNA
9) Confidence 0.65 Published 2006 Journal Reprod Biol Endocrinol Section Body Doc Link PMC1594574 Disease Relevance 0 Pain Relevance 0
Median levels of S100A6 in invasive ductal carcinoma were higher than those in IPMN, and those in pancreatitis-affected epithelial cells tended to be higher than those in normal cells, although these differences were not statistically significant.
Gene_expression (levels) of S100A6 in epithelial cells associated with ductal carcinoma, cancer and pancreatitis
10) Confidence 0.60 Published 2007 Journal Cancer Epidemiol. Biomarkers Prev. Section Abstract Doc Link 17416753 Disease Relevance 1.16 Pain Relevance 0.07
To investigate the regulation of various genes in the uterus of rats during estrous cycle, the expression levels of CaBP-9k, oxytocin, Acrp30, Ldha, and S100a6 mRNA were analyzed by real-time PCR.
Spec (analyzed) Gene_expression (expression) of S100a6 in uterus
11) Confidence 0.50 Published 2006 Journal Reprod Biol Endocrinol Section Body Doc Link PMC1594574 Disease Relevance 0 Pain Relevance 0
The expression levels of representative genes, i.e., calbindin-D9k (CaBP-9k; vitamin D-dependent calcium-binding protein), oxytocin, adipocyte complement related protein (MW 30 kDa), lactate dehydrogenase A and calcium binding protein A6 (S100a6; calcyclin), were confirmed in these tissues by real-time PCR.
Gene_expression (expression) of S100a6 in adipocyte
12) Confidence 0.50 Published 2006 Journal Reprod Biol Endocrinol Section Abstract Doc Link PMC1594574 Disease Relevance 0 Pain Relevance 0
In addition, the expression patterns of CaBP-9k, oxytocin, Acrp, Ldha, and calcyclin mRNAs were altered in the uterus of immature rats during the estrous cycle.
Gene_expression (expression) of calcyclin in uterus
13) Confidence 0.49 Published 2006 Journal Reprod Biol Endocrinol Section Body Doc Link PMC1594574 Disease Relevance 0 Pain Relevance 0
The expression levels of representative genes, i.e., calbindin-D9k (CaBP-9k; vitamin D-dependent calcium-binding protein), oxytocin, adipocyte complement related protein (MW 30 kDa), lactate dehydrogenase A and calcium binding protein A6 (S100a6; calcyclin), were confirmed in these tissues by real-time PCR.
Gene_expression (expression) of calcyclin in adipocyte
14) Confidence 0.44 Published 2006 Journal Reprod Biol Endocrinol Section Abstract Doc Link PMC1594574 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox